<p>The C57/Bl6 mice were implanted with diffusion chambers containing LLC cells. Seven days after implantation, the mice were treated with PLA-695 (7.5 mg/Kg of body weight) or vehicle control for 30 min prior to IR (3 Gy). Fourteen days after implantation, the animals were sacrificed and the skin fold covering the diffusion chamber was analyzed. Shown are representative micrographs indication the tumor-induced neovasculature (black arrow) and pre-existing vasculature (blue arrow) and the bar graph depicting the mean number of neovasculature (>10 field for each mouse) SEM from each treatment group of 5 mice; * p<0.05.</p
PURPOSE: The combination of irradiation and the antiangiogenic compound SU5416 was tested and compar...
<p>(A) The data represent mean tumor volumes ± SEM in 16K-Ad-treated (n = 8) or Null-Ad-treated (n =...
<p>HUVEC and bEND3 cells were plated on 60 mm plates and allowed to grow to 80% confluency. The semi...
<p>C57/BL6 mice with LLC tumors received i.p. injections of vehicle or 7.5 mg/kg PLA-695 30 min prio...
<p>Histologically stained and analyzed sections after treatments of TS/A tumors: intratumoral inject...
<p>LLC or A549 cells were implanted into the right footpad of C57/BL6 mice. Tumors were irradiated w...
<p>(A) Assessment of vascularity with immunofluorescence microscopy in Matrigel implants containing ...
<p>(A) Central marrow ECs, PlGF knockdown central marrow ECs, central marrow SCs or PBS were transpl...
<p>LLC tumor-bearing C57BL6/J mice were systemically treated with control saline or with 2.5 mg/kg/d...
<p>BM MNCs isolated from Tie2/LacZ mice were used to transplant lethally irradiated syngeneic FVB/NJ...
BackgroundThe high incidence of cardiovascular events in cancer survivors has long been noted, but t...
<p>Equal numbers of bEND3, HUVEC, LLC and A549 cells were plated in 96 well plates and treated with ...
<p>Swiss and C57BL/6 mice were pretreated with NLGP (25µg) once a week for four weeks in total follo...
<p>Matrigel plugs containing PBS (Control), or VEGF (100 ng/ml) were implanted subcutaneously in mic...
<p>(<b>A</b>) Evolution of the tumor volume in mice pretreated with i.v. injections every 2 days of ...
PURPOSE: The combination of irradiation and the antiangiogenic compound SU5416 was tested and compar...
<p>(A) The data represent mean tumor volumes ± SEM in 16K-Ad-treated (n = 8) or Null-Ad-treated (n =...
<p>HUVEC and bEND3 cells were plated on 60 mm plates and allowed to grow to 80% confluency. The semi...
<p>C57/BL6 mice with LLC tumors received i.p. injections of vehicle or 7.5 mg/kg PLA-695 30 min prio...
<p>Histologically stained and analyzed sections after treatments of TS/A tumors: intratumoral inject...
<p>LLC or A549 cells were implanted into the right footpad of C57/BL6 mice. Tumors were irradiated w...
<p>(A) Assessment of vascularity with immunofluorescence microscopy in Matrigel implants containing ...
<p>(A) Central marrow ECs, PlGF knockdown central marrow ECs, central marrow SCs or PBS were transpl...
<p>LLC tumor-bearing C57BL6/J mice were systemically treated with control saline or with 2.5 mg/kg/d...
<p>BM MNCs isolated from Tie2/LacZ mice were used to transplant lethally irradiated syngeneic FVB/NJ...
BackgroundThe high incidence of cardiovascular events in cancer survivors has long been noted, but t...
<p>Equal numbers of bEND3, HUVEC, LLC and A549 cells were plated in 96 well plates and treated with ...
<p>Swiss and C57BL/6 mice were pretreated with NLGP (25µg) once a week for four weeks in total follo...
<p>Matrigel plugs containing PBS (Control), or VEGF (100 ng/ml) were implanted subcutaneously in mic...
<p>(<b>A</b>) Evolution of the tumor volume in mice pretreated with i.v. injections every 2 days of ...
PURPOSE: The combination of irradiation and the antiangiogenic compound SU5416 was tested and compar...
<p>(A) The data represent mean tumor volumes ± SEM in 16K-Ad-treated (n = 8) or Null-Ad-treated (n =...
<p>HUVEC and bEND3 cells were plated on 60 mm plates and allowed to grow to 80% confluency. The semi...